ATE340271T1 - Transfektionskinetik und strukturelle promotoren - Google Patents

Transfektionskinetik und strukturelle promotoren

Info

Publication number
ATE340271T1
ATE340271T1 AT02782194T AT02782194T ATE340271T1 AT E340271 T1 ATE340271 T1 AT E340271T1 AT 02782194 T AT02782194 T AT 02782194T AT 02782194 T AT02782194 T AT 02782194T AT E340271 T1 ATE340271 T1 AT E340271T1
Authority
AT
Austria
Prior art keywords
structural
promotors
kinetics
transfection
transfection kinetics
Prior art date
Application number
AT02782194T
Other languages
English (en)
Inventor
C Satishchandran
Catherine J Pachuk
Original Assignee
Nucleonics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nucleonics Inc filed Critical Nucleonics Inc
Application granted granted Critical
Publication of ATE340271T1 publication Critical patent/ATE340271T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Lubricants (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02782194T 2001-10-22 2002-10-22 Transfektionskinetik und strukturelle promotoren ATE340271T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34278801P 2001-10-22 2001-10-22

Publications (1)

Publication Number Publication Date
ATE340271T1 true ATE340271T1 (de) 2006-10-15

Family

ID=23343276

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02782194T ATE340271T1 (de) 2001-10-22 2002-10-22 Transfektionskinetik und strukturelle promotoren

Country Status (7)

Country Link
EP (1) EP1444363B1 (de)
AT (1) ATE340271T1 (de)
AU (2) AU2002348372B2 (de)
CA (1) CA2464464A1 (de)
DE (1) DE60214877T2 (de)
DK (1) DK1444363T3 (de)
WO (1) WO2003035910A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897382B2 (en) 2001-10-22 2011-03-01 Alnylam Pharmaceuticals, Inc. Transfection kinetics and structural promoters
WO2004094654A2 (en) 2003-04-22 2004-11-04 Nucleonics, Inc. Transfection kinetics and structural promoters
TW200613554A (en) * 2004-06-17 2006-05-01 Wyeth Corp Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
EP2772541A3 (de) 2004-09-24 2014-09-24 Alnylam Pharmaceuticals Inc. Targeting von Zwischenprodukten zur Gegenstrangreplikation von Hepatitis C Virus durch RNAi

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9400522D0 (sv) * 1994-02-16 1994-02-16 Ulf Landegren Method and reagent for detecting specific nucleotide sequences
US5849727A (en) * 1996-06-28 1998-12-15 Board Of Regents Of The University Of Nebraska Compositions and methods for altering the biodistribution of biological agents

Also Published As

Publication number Publication date
AU2002348372B2 (en) 2008-08-28
CA2464464A1 (en) 2003-05-01
AU2002348372A2 (en) 2003-05-06
DE60214877D1 (de) 2006-11-02
WO2003035910A1 (en) 2003-05-01
DE60214877T2 (de) 2007-02-15
AU2008249197B2 (en) 2012-01-19
EP1444363B1 (de) 2006-09-20
WO2003035910A9 (en) 2004-12-23
EP1444363A4 (de) 2004-12-15
AU2008249197A1 (en) 2008-12-18
DK1444363T3 (da) 2007-01-29
EP1444363A1 (de) 2004-08-11

Similar Documents

Publication Publication Date Title
ZA200603731B (en) Plasmid system for multiple expression
PT1913001E (pt) (r)-n-metilnaltrexona, processos para a sua síntese e sua utilização farmacêutica
IL226717A (en) Isolated nucleic acids encoded by anti-beta human antibodies 7
MXPA05014016A (es) Proteinas portadoras para vacunas.
CY1108747T1 (el) Παρασκευες ενος σουλφινυλο ακεταμιδιου
TW200604149A (en) Norbornane based cycloaliphatic compounds containing nitrile groups
DK1440151T3 (da) Fröspecifik 7S-a-promotor til at udtrykke gener i planter
SG169325A1 (en) Promoters for expression in modified vaccinia virus ankara
DE60214877D1 (de) Transfektionskinetik und strukturelle promotoren
WO2004046293A3 (en) Amphoteric fluorescent whitening agents
GB0324656D0 (en) A protein involved in ovarian cancer
ATE466079T1 (de) Nukleinsäure konstrukten, pharmazeutische kompositionen und methoden für die behandlung von krebs
BRPI0516576A (pt) vetores quiméricos
ATE548343T1 (de) Umsetzungsprodukte von 2-propylheptanol mit 1- halogen-2,3-epoxypropanen und 1-hydroxy-2,3- epoxypropan
WO2004094654A3 (en) Transfection kinetics and structural promoters
EP1183330A4 (de) Kv10.1, EIN NEUER POTENTIAL-ABHÄNGIGER KALIUMKANAL DES MENSCHLICHEN GEHIRNS
WO2003087840A3 (en) Protein involved in cancer
DK1664093T3 (da) Antitumorforbindelser baseret på kahalalid F
DE602004021567D1 (de) Antikörper gegen tumorspezifisches antigen als ziel
DE50312368D1 (de) Rekombinante mva-stamme als potentielle impfstoffe gegen p. falciparum -malaria
ATE489368T1 (de) Pyrimidinonverbindungen als calcilytica
TW200604154A (en) Norbornane based cycloaliphatic compounds containing methylene amine groups
DE50303586D1 (de) Methylthiophencarboxanilide
AU2003274904A1 (en) Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity
CY1105699T1 (el) Νεες φαρμακευτικες ενωσεις με αλφα2υποδοχεα δραστηριοτητας

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1444363

Country of ref document: EP

EEIH Change in the person of patent owner